News – Page 928 – Endpoints News

After watching its share price soar on a Bloomberg report and heated rumors, Biohaven stock takes a billion-dollar ...

6 years ago

Roche fields first approval for Rozlytrek in the run-up to a showdown with Bayer, Pfizer

6 years ago

The top 10 blockbuster drugs in the late-stage pipeline — Evaluate adds 6 new therapies to heavy-hitter list

6 years ago

AstraZeneca/Merck win EU approval for frontline maintenance treatment of ovarian cancer, months after FDA endorsement

6 years ago

AstraZeneca spinout Viela Bio pockets $75M on its way to BLA for autoimmune drug

6 years ago

A unicorn stalks Wall Street in search of IPO cash; CASI Pharma in-licenses CD19 therapy from China’s Juventas

6 years ago

Drugmakers sue HHS for trying to add prices to DTC ads

6 years ago

Sanofi Genzyme deserts gene therapy developer Voyager Therapeutics

6 years ago

Investors fret as VBI's hep B vaccine fails key secondary PhIII study goal

6 years ago

As Bristol-Myers/Celgene tie up loose ends, BeiGene pockets $150M from PD-1 breakup

6 years ago

Gene therapy R&D deals turn red hot as Big Pharma steps up to play

6 years ago

Pfizer CEO Albert Bourla is back in the M&A game, but why is he paying $11.4B for Array?

6 years ago

Fueled by early success, Enanta paves way for mid-stage RSV study in adult patients later this year

6 years ago

Philadelphia champions life sciences 'co-working,' reviving former GSK campus in $500M makeover

6 years ago

Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report

6 years ago

Newsmakers at #EHA19: Regeneron, ArQule track progress on response rates

6 years ago

Chi-Med cuts surufatinib PhIII short; FDA greenlights Herceptin copycat from Amgen, Allergan

6 years ago

Tariq Kassum jumps from Obsidian to Celsius helm; Quell Therapeutics taps Iain McGill as new CEO

6 years ago

Under siege, investment manager Woodford faces another investment shock

6 years ago

BeiGene touts 'encouraging' response rates as the Chinese biotech mounts challenge to BTK, PD-1 leaders

6 years ago

Global Blood Therapeutics poised to submit application for accelerated approval, with new pivotal data on its sickle ...

6 years ago

Bluebird shares sink as analysts puzzle out $1.8M sticker shock and an unexpected delay

6 years ago

FDA warns of one death linked to fecal transplants

6 years ago

GSK's Barron joins hands with Doudna, Weissman to deploy CRISPR tech in drug discovery

6 years ago

First page Previous page 925 926 927928929 930 931 Next page Last page